ArticleAlimentary pharmacology & therapeutics2022

Editorial: risk of loss of response to anti-TNFα agents in patients with inflammatory bowel disease-the longer the less?

Idan Goren et al.PubMed ↗Publisher ↗

No numbers read from the abstract.